Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$40.23 - $47.74 $36.2 Million - $42.9 Million
-899,142 Closed
0 $0
Q4 2021

Feb 14, 2022

SELL
$38.88 - $45.31 $34.8 Million - $40.6 Million
-896,293 Reduced 49.92%
899,142 $39.7 Million
Q3 2021

Nov 12, 2021

SELL
$38.79 - $43.16 $3.35 Million - $3.72 Million
-86,297 Reduced 4.59%
1,795,435 $68.6 Million
Q2 2021

Aug 16, 2021

SELL
$36.52 - $41.46 $1.29 Million - $1.46 Million
-35,328 Reduced 1.84%
1,881,732 $74.9 Million
Q1 2021

May 17, 2021

SELL
$34.27 - $40.01 $14.1 Million - $16.4 Million
-411,012 Reduced 17.65%
1,917,060 $68.4 Million
Q4 2020

Feb 16, 2021

BUY
$34.07 - $39.94 $71.3 Million - $83.6 Million
2,093,158 Added 891.03%
2,328,072 $85.7 Million
Q3 2020

Nov 16, 2020

SELL
$38.11 - $42.99 $2.21 Million - $2.49 Million
-58,000 Reduced 19.8%
234,914 $8.84 Million
Q2 2020

Aug 14, 2020

SELL
$37.87 - $43.58 $147 Million - $169 Million
-3,874,651 Reduced 92.97%
292,914 $11.9 Million
Q1 2020

May 14, 2020

BUY
$32.47 - $48.83 $25.4 Million - $38.1 Million
780,831 Added 23.06%
4,167,565 $161 Million
Q4 2019

Feb 14, 2020

BUY
$42.0 - $48.25 $133 Million - $153 Million
3,170,411 Added 1465.59%
3,386,734 $159 Million
Q3 2019

Nov 14, 2019

BUY
$40.46 - $43.52 $150,430 - $161,807
3,718 Added 1.75%
216,323 $9.23 Million
Q2 2019

Aug 15, 2019

BUY
$39.4 - $42.7 $325,365 - $352,616
8,258 Added 4.04%
212,605 $8.51 Million
Q1 2019

May 14, 2019

BUY
$38.57 - $42.69 $231,227 - $255,926
5,995 Added 3.02%
204,347 $8.54 Million
Q4 2018

Feb 14, 2019

SELL
$37.8 - $42.69 $79,304 - $89,563
-2,098 Reduced 1.05%
198,352 $7.58 Million
Q3 2018

Nov 13, 2018

BUY
$39.75 - $42.69 $8,069 - $8,666
203 Added 0.1%
200,450 $8.05 Million
Q2 2018

Aug 14, 2018

BUY
$39.61 - $42.76 $29,747 - $32,112
751 Added 0.38%
200,247 $8.07 Million
Q1 2018

May 14, 2018

BUY
$36.18 - $40.15 $7.22 Million - $8.01 Million
199,496 New
199,496 $7.79 Million

Others Institutions Holding GSK

About GSK PLC


  • Ticker GSK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,033,689,984
  • Market Cap $69.3B
  • Description
  • GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...
More about GSK
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.